AbbVie Inc (NYSE:ABBV) (CNBC) AbbVie, the maker of the world’s best selling drug, reported fourth-quarter profit on Friday that beat Wall Street......
(read more)January 26 - Market Movers, News - Comments
1. U.S. Stock Market: “U.S. stocks pulled back on Tuesday after the S&P 500 and the Nasdaq Composite hit record intraday highs as a decline......
(read more)May 16 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. U.S. Stock Market: “U.S. equities traded mostly lower on Friday as investors digested a tough week for retailers as well as mixed economic......
(read more)May 12 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. U.S. Stock Market: “U.S. stocks wavered on Wednesday as investors digested a batch of weak corporate earnings and President Donald Trump&#......
(read more)May 10 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing SECURITIES AND EXCHANGE COMMISSION......
(read more)April 19 - Hedge Funds - Comments
Shares of MannKind Corporation (NASDAQ:MNKD) initially surged sharply higher by over 20% on Friday before pulling back after Bloomberg reported that ......
(read more)April 7 - Market Movers, News - Comments
1. US Stock Market: “Stocks rose slightly on Friday afternoon as investors parsed through a mixed employment report, a U.S. airstrike in Syria......
(read more)April 7 - Commodities, Gold, Market Movers, News, Tech - Comments
Last week we saw plenty of volatility across the healthcare and biotechnology sectors, driven both by macro and micro factors. We’re expecting much......
(read more)March 6 - News, Stock Analysis - Comments
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating......
(read more)December 15 - Hedge Funds, News - Comments
We at Insider Monkey have consistently followed hedge funds and institutional investors to help investors earn attractive returns through equity investment......
(read more)November 30 - Hedge Funds, News - Comments
MannKind Corporation (NASDAQ:MNKD) has had a rough time in the market for a couple years at this point, and for good reason. The company simply can&#......
(read more)October 14 - News, Stock Analysis - Comments
MannKind Corporation (NASDAQ:MNKD) recently presented data on its inhaled insulin candidate, Afrezza. The company’s presentation compared the action......
(read more)June 13 - News, Stock Analysis - Comments
U.S. stocks are up for a third consecutive trading session on Tuesday, largely driven by a marked surge in oil prices and a weakening Yen. However, as......
(read more)May 10 - Market Movers, News - Comments
All three major indexes are in the red on Wednesday after Apple Inc. (NASDAQ:AAPL) reported a disappointing quarter. Among the stocks that are deep-in......
(read more)April 27 - Market Movers, News - Comments
With the NASDAQ index in the red and the S&P 500 and Dow Jones Indexes barely in the green, shares of Highpower International Inc (NASDAQ:HPJ), Chesapeake......
(read more)April 12 - Market Movers, News - Comments
The markets are surging on Monday, with all major U.S stock indexes, as well as oil and gold trading up. Of course, not all stocks are benefiting from......
(read more)April 11 - Market Movers, News - Comments
The US Stock Market is quite flattish on Monday, with major indexes posting small gains. However, a few stocks like Pandora Media Inc (NYSE:P), MannKind......
(read more)March 28 - Market Movers, News - Comments
The stock market is up slightly on Monday, with major U.S stock indexes posting gains of between 0.1% and 0.2%. Oil prices are accompanying the surge......
(read more)March 21 - Market Movers, News - Comments
With all three indices in the red today, several stocks opened lower and registered considerable losses in morning trading. In this article we are going......
(read more)January 5 - Market Movers, News - Comments
Does MannKind Corporation (NASDAQ:MNKD) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund sentiment towards the......
(read more)November 25 - Hedge Funds, News - Comments
The decline of the U.S. stocks is continuing for the third day straight, after disappointing economic data put downward pressure on the market. The energy......
(read more)November 13 - Market Movers, News, Tech - Comments
With the broader market down by more than half a percent, shares of International Game Technology Ordinary Shares (NYSE:IGT), Freshpet Inc (NASDAQ:FRPT......
(read more)November 12 - Market Movers, News - Comments
The US stock market inched down on Tuesday amid concerns regarding the Chinese economy and a coming rate hike. In the first hours of trading most stocks......
(read more)November 10 - Earnings Report, Market Movers, News, Tech - Comments
On a day where the S&P 500 is up by 0.82% and the NASDAQ is up by over 1%, shares of Green Brick Partners Inc (NASDAQ:GRBK), MannKind Corporation (......
(read more)November 2 - Market Movers, News - Comments
Shares of MannKind Corporation (NASDAQ:MNKD) got crushed on Wednesday, ending the day down by 10.07%, on the back of a research note published by Piper......
(read more)September 11 - Hedge Funds, News, Stock Analysis - Comments
According to CNBC, Tourbillon Capital’s Jason Karp is betting on a decline of MannKind Corporation (NASDAQ:MNKD) shares. “Only in a frothy......
(read more)July 24 - Hedge Funds, News, Stock Analysis - Comments
Here’s your one-question pop quiz of the day. Does MannKind Corporation (NASDAQ:MNKD) deserve a market cap of: $1.4 billion $1.7 billion $2.2 billion......
(read more)September 17 - News - Comments
In pharmacology, we don’t only have to consider the actions of the drug on the body. It is also important to understand the way the body processes......
(read more)September 12 - News - Comments
MannKind Corporation (NASDAQ:MNKD) has been struggling to get its inhalable insulin product Afrezza on the market; the product was sent back to the labs......
(read more)September 12 - News - Comments
Editor’s Note: MannKind Corporation (NASDAQ:MNKD) MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference (Market Watch......
(read more)September 5 - News - Comments
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age. Although there are more than......
(read more)September 4 - News - Comments
Should PDL BioPharma Inc. (NASDAQ:PDLI) investors track the following data? In the eyes of many market players, hedge funds are seen as overrated, old......
(read more)September 3 - News - Comments
What’s a smart Puma Biotechnology Inc (NYSE:PBYI) investor to do? In today’s marketplace, there are dozens of methods market participants can......
(read more)September 3 - News - Comments
Talk to MannKind Corporation (NASDAQ:MNKD) bulls, and you’ll hear two reasons why its insulin Afrezza is the best thing since sliced bread. The......
(read more)September 2 - News - Comments
Editor’s Note: Related tickers: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD), J.C.......
(read more)August 30 - News - Comments
What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly......
(read more)August 30 - News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......
(read more)August 29 - Hedge Funds - Comments
This week, MannKind Corporation (NASDAQ:MNKD) published a set of frequently asked questions about the recent clinical trials for its inhaled insulin Afrezza......
(read more)August 28 - News - Comments
In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and......
(read more)August 28 - News - Comments
While I do think it’s possible that MannKind Corporation (NASDAQ:MNKD)‘s inhaled insulin device, Afrezza, will be approved by the Food and......
(read more)August 22 - News - Comments
Are you curious what the richest investors think about VIVUS, Inc. (NASDAQ:VVUS)? In the 21st century investor’s toolkit, there are dozens of metrics......
(read more)August 22 - News - Comments
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we’ve seen from the smart money, out of the entire stock market......
(read more)August 22 - News - Comments
Editor’s Note: MannKind Corporation (NASDAQ:MNKD) MannKind Corporation (NASDAQ:MNKD) entrenched firmly in second Tranche of financing (GSPInsider......
(read more)August 20 - News - Comments
It’s no wonder that plenty of companies are developing diabetes drugs. There are more than 370 million people with diabetes worldwide. The global......
(read more)August 20 - News - Comments
How do you track the value of companies you’re invested in? If you’re like most people, you probably check the increase or decrease in share......
(read more)August 19 - News - Comments
With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......
(read more)August 19 - News - Comments
While the major indexes pulled back this week, their declines paled in comparison to the huge drops experienced by a handful of health-care stocks. Here......
(read more)August 19 - News - Comments
There’s never a shortage of losers in the stock market. Let’s take a closer look at five of this past week’s biggest sinkers. Company......
(read more)August 19 - News - Comments
If you’re feeling good about the market, you’re not alone. Take my hand as we go over some of this week’s more uplifting headlines.......
(read more)August 17 - News - Comments
Editor’s Note: MannKind Corporation (NASDAQ:MNKD) MannKind rewarded for positive Afrezza data with $40M financing (FierceBiotech) MannKind’......
(read more)August 16 - News - Comments
